All Stories

  1. Aging Biomarker SMP30 into a New Phase of Vitamin C and Aging Research
  2. Age-associated changes in the transcriptomes of non-cultured adipose-derived stem cells from young and old mice assessed via single-cell transcriptome analysis
  3. Role of Ascorbic Acid in Skeletal Muscle Regeneration
  4. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interlukin-6
  5. Anti-aging effects of coffee
  6. Coffee consumption in aged mice increases energy production and decreases hepatic mTOR levels
  7. Update on Deimination in Alzheimer’s Disease
  8. Induction of peptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells
  9. Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease
  10. Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease, asthma-COPD overlap syndrome and bronchial asthma
  11. Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains
  12. Age-associated decrease of senescence marker protein-30/gluconolactonase in individual mouse liver cells: Immunohistochemistry and immunofluorescence
  13. Potato Chip Intake Increases Ascorbic Acid Levels and Decreases Reactive Oxygen Species in SMP30/GNL Knockout Mouse Tissues
  14. Senescence marker protein‐30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes
  15. Ascorbic acid deficiency affects genes for oxidation–reduction and lipid metabolism in livers from SMP30/GNL knockout mice
  16. P43 Ascorbic acid deficiency augments hyperalgesia induced by hydrogen sulfide in mice
  17. Vitamin C and Physical Performance in the Elderly
  18. Senescence marker protein‐30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis
  19. Senescence Marker Protein 30 Has a Cardio-Protective Role in Doxorubicin-Induced Cardiac Dysfunction
  20. Smad3 Deficiency Ameliorates Hepatic Fibrogenesis through the Expression of Senescence Marker Protein-30, an Antioxidant-Related Protein
  21. Ascorbic acid prevents protein oxidation in livers of senescence marker protein-30/gluconolactonase knockout mice
  22. Effects of Vitamin C on Cytotherapy-Mediated Muscle Regeneration
  23. Coronary Artery Spasm Related to Thiol Oxidation and Senescence Marker Protein-30 in Aging
  24. Deimination in Alzheimer’s Disease
  25. Deimination in Prion Diseases
  26. Vitamin C Prevents Cigarette Smoke-Induced Pulmonary Emphysema in Mice and Provides Pulmonary Restoration
  27. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction
  28. Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis
  29. Leprdb/db Mice with Senescence Marker Protein-30 Knockout (Leprdb/dbSmp30Y/−) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet
  30. Senescence Marker Protein-30 (SMP30) Deficiency Impairs Myocardium-Induced Dilation of Coronary Arterioles Associated with Reactive Oxygen Species
  31. Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes
  32. Senescence marker protein 30 deficiency increases Parkinson's pathology by impairing astrocyte activation
  33. Effect of ascorbic acid deficiency on catecholamine synthesis in adrenal glands of SMP30/GNL knockout mice
  34. Age-related oxidant stress with senescence marker protein-30 deficiency plays a pivotal role in coronary artery spasm
  35. Insufficient ascorbic acid intake during gestation induces abnormal cardiac dilation in fetal and neonatal SMP30/GNL knockout mice
  36. Structural Basis of the γ-Lactone-Ring Formation in Ascorbic Acid Biosynthesis by the Senescence Marker Protein-30/Gluconolactonase
  37. Senescence Marker Protein-30/Gluconolactonase Expression in the Mouse Ovary during Gestation
  38. Peptidylarginine deiminase and protein citrullination in prion diseases
  39. Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts
  40. Effects of Ascorbic Acid Deficiency on Protein and Lipid Oxidation in Livers from SMP30/GNL Knockout Mice
  41. The Effect of Vitamin C C-onsumption on the Oxidative Stress Regulation System in SMP30/GNL Knockout Mice
  42. ChemInform Abstract: Synthesis and Evaluation of 4‐Aryl‐2(1H)‐quinolinones as Potent Amyloid β Fibrillogenesis Inhibitors.
  43. Age‐related changes of dopamine, noradrenaline and adrenaline in adrenal glands of mice
  44. Ascorbic Acid Deficiency Leads to Epidermal Atrophy and UVB-Induced Skin Pigmentation in SMP30/GNL Knockout Hairless Mice
  45. Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases
  46. Synthesis and Evaluation of 4-Aryl-2(1H)-quinolinones as Potent Amyloid β Fibrillogenesis Inhibitors
  47. Ascorbic Acid Levels in Various Tissues, Plasma and Urine of Mice during Aging
  48. Uric Acid Levels in Tissues and Plasma of Mice during Aging
  49. Development of a New Distyrylbenzene-Derivative Amyloid-^|^#946;-aggregation and Fibril Formation Inhibitor
  50. Effect of vitamin C depletion on UVR-B induced cataract in SMP30/GNL knockout mice
  51. Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice
  52. 17β-Estradiol attenuates saturated fatty acid diet-induced liver injury in ovariectomized mice by up-regulating hepatic senescence marker protein-30
  53. Bioavailability of vitamin C from mashed potatoes and potato chips after oral administration in healthy Japanese men
  54. Time course of vitamin C distribution and absorption after oral administration in SMP30/GNL knockout mice
  55. Subcellular Localization of Peptidylarginine Deiminase 2 and Citrullinated Proteins in Brains of Scrapie-Infected Mice: Nuclear Localization of PAD2 and Membrane Fraction-Enriched Citrullinated Proteins
  56. Absorption and Excretion of Ascorbic Acid Alone and in Acerola (Malpighia emarginata) Juice: Comparison in Healthy Japanese Subjects
  57. Vitamin C deficiency increases the binucleation of hepatocytes in SMP30 knock‐out mice
  58. Pathophysiological significance of senescence marker protein‐30
  59. Importance of research on peptidylarginine deiminase and citrullinated proteins in age‐related disease
  60. ChemInform Abstract: anti‐Aging Research Using SMP30/GNL Knockout Mice
  61. Corrigendum to “Effects of vitamin C deficiency on the skin of the senescence marker protein-30 (SMP30) knockout mouse” [Biochem. Biophys. Res. Commun. 385 (2009) 478–483]
  62. Vitamin C Deficiency Attenuates Liver Fibrosis by Way of Up-Regulated Peroxisome Proliferator-Activated Receptor-Gamma Expression in Senescence Marker Protein 30 Knockout Mice
  63. Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice
  64. Senescence Marker Protein-30/Gluconolactonase Deletion Worsens Glucose Tolerance through Impairment of Acute Insulin Secretion
  65. Anti-aging Research Using SMP30/GNL Knockout Mice
  66. Advanced Approaches to Anti-aging —Use of Aging Model Animals—
  67. Accumulation of amyloid β-like substances in aging Aplysia kurodai CNS
  68. Determination of Dehydroascorbic Acid in Mouse Tissues and Plasma by Using Tris(2-carboxyethyl)phosphine Hydrochloride as Reductant in Metaphosphoric Acid/Ethylenediaminetetraacetic Acid Solution
  69. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease
  70. Effect of vitamin C depletion on age-related hearing loss in SMP30/GNL knockout mice
  71. Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
  72. Developmental and age‐related changes of peptidylarginine deiminase 2 in the mouse brain
  73. Effects of vitamin C deficiency on the skin of the senescence marker protein-30 (SMP30) knockout mouse
  74. Senescence marker protein 30 is up‐regulated in kainate‐induced hippocampal damage through ERK‐mediated astrocytosis
  75. Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression
  76. Over-expression of Senescence Marker Protein-30 Decreases Reactive Oxygen Species in Human Hepatic Carcinoma Hep G2 Cells
  77. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease
  78. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice
  79. Accumulation of Citrullinated Proteins by Up-Regulated Peptidylarginine Deiminase 2 in Brains of Scrapie-Infected Mice
  80. Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice
  81. Age-related difference of site-specific histone modifications in rat liver
  82. Myasthenia Gravis Experimentally Induced with Muscle‐specific Kinase
  83. Germ Cell-Specific Expression and Biochemical Characterization of Mouse PAD6.
  84. Hepatoprotective effect of Arazyme on CCl4-induced acute hepatic injury in SMP30 knock-out mice
  85. Vitamin C Is Not Essential for Carnitine Biosynthesis in Vivo: Verification in Vitamin C-Depleted Senescence Marker Protein-30/Gluconolactonase Knockout Mice
  86. Significance of SMP30 in gerontology
  87. Microglial expression of peptidylarginine deiminase 2 in the prenatal rat brain
  88. Senescence Marker Protein-30 Protects Mice Lungs from Oxidative Stress, Aging, and Smoking
  89. P4–122: Abnormal accumulation of citrullinated proteins in scrapie–infected mouse brain
  90. SMP30 deficiency causes increased oxidative stress in brain
  91. The Redox-Sensitive DNA Binding Sites Responsible for Age-Related Downregulation of SMP30 by ERK Pathway and Reversal by Calorie Restriction
  92. A Selective NF.KAPPA.B Inhibitor, DHMEQ, Reduced Atherosclerosis in ApoE-deficient mice
  93. Citrullination preferentially proceeds in glomerular Bowman's capsule and increases in obstructive nephropathy
  94. Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cells
  95. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease
  96. Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process
  97. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells
  98. Senescence marker protein‐30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver
  99. Senescence Marker Protein‐30 as a Novel Antiaging Molecule
  100. Senescence Marker Protein‐30 Knockout Mouse as an Aging Model
  101. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span
  102. Senescence marker protein‐30 knockout mouse as a novel murine model of senile lung
  103. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I
  104. Nuclear Localization of Senescence Marker Protein-30, SMP30, in Cultured Mouse Hepatocytes and Its Similarity to RNA Polymerase
  105. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin
  106. Senescence Marker Protein-30 Knockout Mouse Liver Is Highly Susceptible to Tumor Necrosis Factor-α- and Fas-Mediated Apoptosis
  107. Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain
  108. Protein Deimination and Peptidylarginine Deiminase Expression during Cornification of Rat Epidermal Keratinocytes
  109. Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes
  110. Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration
  111. Molecular cloning of two novel types of peptidylarginine deiminase cDNAs from retinoic acid‐treated culture of a newborn rat keratinocyte cell line
  112. All-TransRetinoic Acid Increases Peptidylarginine Deiminases in a Newborn Rat Keratinocyte Cell Line
  113. Detection of Deiminated Proteins in Rat Skin: Probing with a Monospecific Antibody After Modification of Citrulline Residues
  114. Age‐related changes in DNA synthesis stimulated by epinephrine and isoproterenol in primary cultured rat hepatocytes
  115. Effect of dietary restriction on the degradation of proteins in senescent mouse liver parenchymal cells in culture
  116. Age-related change in the degradation rate of ovalbumin microinjected into mouse liver parenchymal cells
  117. Inactivation kinetics of horseradish peroxidase microinjected into hepatocytes from mice of various ages